Member Info for ria20

Zak mir just set a new target of 25.00....great time to be in here.....has a long way to climb up .....today is just the start of the rise

Why don't you call the bottom then chizzywizzy47 let see your skills and technical analysis nounce....tell us your bottoms for other shares and happy to listen.....i have timed quite a few correct...lets see if you can do the same...we are only here to find good shares...so happy to see other opinions and views on rock bottom shares pal...have a good day too!

2.5 million buys outstripping sells .....looking great for an afternoon rally .....nice

Will present the study results on Wednesday afternoon at the IP2023 annual conference in Liverpool.

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Gama Aviation PLC, up 62% at 85 pence, 12-month range 45p-99p. The aviation services company agrees to sell its US maintenence, repair and operations business Jet East to West Star Aviation Enterprises LLC. Says the deal for Jet East, the trading name of Gama Aviation (Eng) Inc, has an enterprise value of USD131 million, while net proceeds are around USD100 million. Will review capital requirements of the group, but expects to return net proceeds to shareholders of "not less than 55p per share on a fully diluted basis", including options. Notes sale is conditional upon shareholder approval at a general meeting on November 3, with the transaction expected to complete shortly after. "After interest from several parties, we are delighted to have agreed the sale of Jet East to West Star Aviation. I believe the new owner will be an excellent guardian of our valued strategic relationships and, importantly, the people that deliver critical services to our customers every day," says Chief Executive Officer Marwan Khalek.

----------

Ondine Biomedical Inc, up 62% at 15p, 12-month range 6.86p-29.19p.The Vancouver-based life sciences company celebrates results from a new study showing that its Steriwave treatment dramatically reduced levels of antibiotic-resistant bacteria. The study was evaluating Steriwave's efficacy against Gram-negative and Gram-positive multidrug-resistant and extensively drug-resistant bacteria with novel antibiotic resistance factors. These included "some of the most commonly prescribed antibiotic classes" including penicillin. The study "concluded that photodisinfection is likely an important adjunct to [antimicrobial resistance] strategies in the future and that further clinical studies are warranted", Ondine says. Will present the study results on Wednesday afternoon at the IP2023 annual conference in Liverpool.

----------

Chizzywizzy47 i called the bottom.....patience is a virtue....it doesn't go up in a straight line as is not depleted but up since i bought and happy to be in ....just the beginning of the rise my friend

Now ....please post any media coverage you see on here.....thank you

54 percent happy to stay at this level for the next 45 minutes before we start to motor up later today.....great morning...going to get a mid morning snack now

Buys are now outstripping sells......good morning paulhall99 i was just doubling up on another share that i called the bottom on the other day.....number 2 on the leaderboard right now.....i called the bottom on this too.... pretty good week so far for me

2.4 million buys oustripping sells and fantastic start to the day.....trading volumes massive this morning....expecting a bigger and better afternoon....

Top up on the dip as we are in for a fantastic day

11 percent now ...21.00 on ask

Ondine will present the study results on Wednesday afternoon at the IP2023 annual conference in Liverpool.

(Alliance News) - Ondine Biomedical Inc on Wednesday celebrated results from a new study showing that its Steriwave treatment dramatically reduced levels of antibiotic-resistant bacteria.

Shares in Ondine were up 69% at 15.60 pence in London on Wednesday morning.

The Vancouver-based life sciences company said that according to the controlled in vitro study, treatment with Steriwave photodisinfection reduced the amount of viable bacteria by over 99.9% compared to the control group.

Ondine said the study was evaluating Steriwave's efficacy against Gram-negative and Gram-positive multidrug-resistant and extensively drug-resistant bacteria with novel antibiotic resistance factors. These included "some of the most commonly prescribed antibiotic classes" including penicillin.

The study "concluded that photodisinfection is likely an important adjunct to AMR strategies in the future and that further clinical studies are warranted," Ondine said.

Ondine will present the study results on Wednesday afternoon at the IP2023 annual conference in Liverpool.

"We continue to demonstrate, both clinically in hospitals across Canada and in the lab, that photodisinfection can provide a real alternative to topical antimicrobials...this technology can save millions of lives," proclaimed Chief Executive Officer Carolyn Cross.

She added: "The results of this study are particularly welcome as we prepare for our US Phase 3 trial in partnership with HCA Healthcare who are providing invaluable guidance and support."

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Up ask on 20.00 ....looking ready to move

10 percent ...mms lifting up past 19.00

8 percent ...mms have to let go very soon

5 percent

Thank you .....Davey50 do your own research .....i know you love me and you follow me every day like a sick love puppy....see this stalker posts he mentions my name in every couple of posts......are in you love with me and can't take rejection.....lol

Crossed 200 day moving average .....major breakout ......rsi above 50......technicals all screaming a buy at the price now .....this is just the beginning 20.00+ is coming .....volumes say it all too